ArticleMolecular therapy. Oncology2025

Dual CARM1-and IKZF3-targeting: A novel approach to multiple myeloma therapy synergy between CARM1 inhibition and IMiDs.

Wei Ni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.